Clinical Research Directory
Browse clinical research sites, groups, and studies.
6 clinical studies listed.
Filters:
Tundra lists 6 Intracranial Artery Stenosis clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.
This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.
NCT07170618
Efficacy and Safety of a New Balloon Microcatheter in the Treatment of Intracranial Artery Stenosis
The primary objective of this trial is to evaluate the safety and efficacy of a new balloon microcatheter in patients with intracranial artery stenosis.
Gender: All
Ages: 18 Years - 80 Years
Updated: 2025-09-12
NCT06902740
PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis
This is a prospective, multicenter, open-label, blinded-endpoint, randomized controlled trial designed to evaluate the efficacy and safety of PCSK9 inhibitor combined with statin therapy compared to statin monotherapy in reversing asymptomatic intracranial atherosclerosis, assessed using high-resolution magnetic resonance imaging of the intracranial vessel walls.
Gender: All
Ages: 18 Years - 60 Years
Updated: 2025-08-07
9 states
NCT07085299
Gut Microbiota and Prognostic Outcomes in Intracranial Arterial Stenosis Patients（GROW-ICAS）
GROW-ICAS (Gut microBiota and prOgnostic Outcomes in IntraCranial Arterial Stenosis) is a prospective observational cohort study that enrolls patients with intracranial arterial stenosis to investigate the correlations between their gut microbiota, metabolomic, and transcriptomic profiles and three key clinical domains: functional outcomes, vascular plaque imaging characteristics, and post-stroke non-motor dysfunctions (including cognitive impairment, depression, anxiety, and fatigue).
Gender: All
Ages: 30 Years - 80 Years
Updated: 2025-07-25
1 state
NCT05692882
A Registry Study of Intracranial Atherosclerotic Stenosis Treatment by Intracranial Drug-eluting Stenting in China
The primary objective of this trial is to evaluate the long-term safety and efficacy of the NOVA intracranial drug-eluting stent system in "real world" patients with intracranial atherosclerotic stenosis.
Gender: All
Ages: 18 Years - 85 Years
Updated: 2025-04-01
NCT05397405
Improving Blood Lipid Management in Symptomatic Intracranial Atherosclerotic Stenosis on Clinical Outcome
sICASBLM is a prospective controlled trial, to asses the impact of improving blood lipid management on clinical outcome of moderate to severe symptomatic intracranial atherosclerotic stenosis patients (LDL-C\>1.8mmol/L) without endovascular therapy.
Gender: All
Ages: 18 Years - 85 Years
Updated: 2024-11-15
1 state
NCT06595342
A Prospective Cohort of Patients With Cervical/Intracranial Arteries Stenosis in China
The aim of this study is to establish a prospective cohort of patients with cervical/intracranial arteries stenosis in China.
Gender: All
Ages: 40 Years - 80 Years
Updated: 2024-10-03
1 state